Aromatase inhibition and its pharmacologic implications.
D000733:Androstatrienes / Q000494:pharmacology; D000735:Androstenedione / Q000031:analogs & derivatives / Q000494:pharmacology; D000818:Animals; D001141:Aromatase / Q000378:metabolism; D047072:Aromatase Inhibitors; D001943:Breast Neoplasms / Q000378:metabolism; D004967:Estrogens / Q000096:biosynthesis; D005260:Female; D006801:Humans; D007700:Kinetics; D008253:Macaca mulatta; D008297:Male; D008325:Mammary Neoplasms, Experimental / Q000473:pathology; D008593:Menopause; D009845:Oligospermia / Q000188:drug therapy; D010088:Oxidoreductases / Q000037:antagonists & inhibitors*; D051381:Rats; D014594:Uterine Neoplasms / Q000378:metabolism
D000733:Androstatrienes; D047072:Aromatase Inhibitors; D004967:Estrogens; C011658:androsta-1,4,6-triene-3,17-dione; D000735:Androstenedione; C022569:4-acetoxy-4-androstene-3,17-dione; D010088:Oxidoreductases; D001141:Aromatase; C014594:formestane